Literature DB >> 7554449

Elevated serum level and altered glycosylation of alpha 1-acid glycoprotein in hyperimmunoglobulinemia D and periodic fever syndrome: evidence for persistent inflammation.

E C Havenaar1, J P Drenth, E C van Ommen, J W van der Meer, W van Dijk.   

Abstract

Crossed affinoimmunoelectrophoresis using concanavalin A and Aleuria aurantia lectin as diantennary glycan- and fucose-specific affinocomponents, respectively, was applied to study changes in the concentration and glycosylation of the acute phase protein alpha 1-acid glycoprotein (AGP) in sera obtained from patients with hyperimmunoglobulinemia D and periodic fever syndrome. Increases in concentration of AGP compared to control values were found not only during attacks, but also during remissions. Compared to healthy controls, the presence of diantennary glycan-containing glycoforms of AGP also increased during febrile attacks, while no changes were found during remissions. A continuous high degree of alpha 1-->3 fucosylation was accompanied by a continuous high expression of sialyl Lewisx on AGP. Despite the clinical picture of recurrent febrile attacks with asymptomatic intervals, these studies indicate that hyperimmunoglobulinemia D should be considered a condition of persistent inflammation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554449     DOI: 10.1006/clin.1995.1126

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  6 in total

1.  Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells.

Authors:  J P Drenth; J Göertz; M R Daha; J W van der Meer
Journal:  Immunology       Date:  1996-07       Impact factor: 7.397

Review 2.  Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis.

Authors:  G Lamblin; S Degroote; J M Perini; P Delmotte; A Scharfman; M Davril; J M Lo-Guidice; N Houdret; V Dumur; A Klein; P Rousse
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

3.  Specific glycosylation of alpha(1)-acid glycoprotein characterises patients with familial Mediterranean fever and obligatory carriers of MEFV.

Authors:  D C Poland; J P Drenth; E Rabinovitz; A Livneh; J Bijzet; B van het Hof; W van Dijk
Journal:  Ann Rheum Dis       Date:  2001-08       Impact factor: 19.103

4.  Do synovial fluid acute phase proteins from patients with rheumatoid arthritis originate from serum?

Authors:  E C Havenaar; R J Dolhain; G A Turner; M T Goodarzi; E C van Ommen; F C Breedveld; W van Dijk
Journal:  Glycoconj J       Date:  1997-06       Impact factor: 2.916

5.  Fucosylation of serum alpha1-acid glycoprotein in rheumatoid arthritis patients treated with infliximab.

Authors:  Anna Olewicz-Gawlik; Izabela Korczowska-Łacka; Jan K Łacki; Kamilla Klama; Paweł Hrycaj
Journal:  Clin Rheumatol       Date:  2007-02-20       Impact factor: 2.980

6.  30 years hids-Travels between bedside and bench.

Authors:  Jos W M van der Meer
Journal:  Temperature (Austin)       Date:  2015-02-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.